Registration: Improving MAT Access and Quality Through Collaborative Care: The CoOp Model - Webinar
Medication assisted treatments (MAT) enhance opioid use disorder treatment efficacy, yet remain underutilized. Opioid treatment programs (OTPs) can now dispense buprenorphine or naltrexone as well as methadone. Collaboration between OTPs and office-based buprenorphine (OBB) prescribers constitutes a cohesive model providing access to comprehensive services, and encouraging MAT prescribing. During this webinar Dr. Stoller will focus on a model of care he coined “Collaborative Opioid Prescribing (CoOP),” linking OTP expertise with OBB prescribers. The OTP provides assessment, buprenorphine induction, and counseling, while OBB physicians provide ongoing buprenorphine prescribing and somatic or psychiatric care. An adaptive stepped care model adjusts counseling intensity and medication parameters (OBB prescription vs. OTP dispensing; duration of prescriptions). Supporting OBB providers in this manner may encourage MAT provision and access, while concurrently improving treatment outcome. Providing a broad spectrum of medical, social, and recovery services through coordinated care can enhance health outcomes and address unmet patient needs.